|
|
|
Pharmaceutical Manufacturing and Packing Sourcer |
|
|
|
|
|
 |
| |
|
|
|
|
Industry Insight
Editor Graham Hughes considers the long way that advancements have come in terms of robotics and automation technology, and comments on the array of articles on offer in this edition of PMPS.
|
|
|
|
|
Protective Packaging
Child’s Eye View
Pauline Pang and Melissa B Green of Honeywell Healthcare and Packaging discuss how pharma companies can work with government institutions to develop effective solutions and best practices for child-resistant packaging.
|
|
|
Blister Barriers
Pack Perfection
Changing packaging can raise concerns of complexity, but with blister packs meeting all the critical aspects of pharma packaging, companies are increasingly making the move. Philip Cooper at Sepha explains how to achieve the perfect blister.
|
|
|
Anti-Counterfeiting
Security Systems
Essentra’s Martin Dallas reveals how the implementation of new packaging security techniques can ensure a robust and reliable defence against tampering and copying, in addition to brand protection.
|
|
|
|
Clinical Site Supply
Preparing for the Journey
With many obstacles affecting the implementation of a reliable clinical supply chain process, Mark Cadman and Jens Mattuschka at PAREXEL International address risk assessment and mitigation.
|
|
|
Secondary Trial Packaging
Beyond the Label
Frank Jäger and Nurdan Citamak from Faubel examine the evolution of labels to multi-purpose tools, which they say has been prompted by pressures of quality and userfriendliness, as well as the need for shorter development lead times.
|
|
|
|
Case Study: Dry Powder Inhalation
In and Out
As pulmonary inhalation begins to move into new therapeutic areas, Peter Villax and Gonçalo Andrade at Hovione investigate the engineering behind the first factory-filled, single-use dry powder inhaler to come to market.
|
|
|
Inhaled Drug Delivery
Open Wide
Recently, there has been a growing interest in the use of inhaled drug delivery to manage systemic conditions such as diabetes or pain. Kish Mistry and Mike Davies from Pulmorphix explore the huge appeal of orally inhaled products.
|
|
|
|
Biopharma Cargo
Life After the Patent Cliff
With the pharma industry facing a period of great upheaval, Alan Dorling from IAG Cargo considers the need to invest in the right infrastructure to ensure the safe transportation of products across the globe.
|
|
|
Supply Chain Trends
From A to B
The life sciences and healthcare industry must adapt to a new supply chain business model, as the old system is simply not resilient enough to face the huge pressures in today’s market, argues Lisa Harrington from lharrington group.
|
|
|
|
Offshoring and Outsourcing
Intellectual Thinking
Jackie Maguire at Coller IP reminds us that while collaboration and outsourcing may seem straightforward, any organisation considering this model should be aware of the need to secure its intellectual property.
|
|
|
Asset Management
Taking Stock
In every business there are under-utilised assets that would serve a better purpose being redeployed, sold or destroyed. Ben Potenza at EquipNet recommends proactive asset management to allow companies to maximise their resources.
|
|
|
|
Q&A: Processing and Packaging
Exhibiting Progress
With preparations for the upcoming PPMA Show under way, PMPS interviews Grant Collier, the event’s Head of Marketing and Publishing, to find out which manufacturing trends he predicts will be key over the next decade.
|
|
|
Colour Masterbatches
The Challenge of Change
Steve Duckworth at Clariant tells PMPS about the colourful world of masterbatches, emphasising the importance of being one step ahead of regulatory restrictions to protect both pharma customers and patients.
|
|
|
|
|
Q&A: Robotic Solutions
Automated Answers
To attempt to manufacture drugs without automation seems inconceivable today, and AUTOMATICA’s Armin Wittmann is convinced that pharma can keep learning from other industries in the search for ever-more efficient solutions.
|
|
|
Bespoke Automation
A Robot’s Tale
Robots can provide businesses with the ability to lower all-round capital costs and gain a fast payback time on an initial investment. With a rise in affordable and simpler robotics, Peter Richards at Armstrong UEN believes that increased automation is the way forward.
|
|
|
GAMP and Validation
Best Practice
With the need for pharma manufacturers to focus less on eliminating contingency and more on using systems that perform as expected, David Jones at Yokogawa UK highlights the importance of observing Good Automated Manufacturing Practice.
|
|
|
|
|
The End of the Line
A Friend in Need
Richard Harrop thinks ‘outside of the box’ as he ponders how packaging can be designed to improve quality of life, simply by focusing on a more user-friendly experience.
|
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
Northway Biotechpharma enters into Development and Manufacturing Agreement with Synklino
Vilnius, Lithuania, and Copenhagen, Denmark – December 18th 2019 – Northway Biotechpharma, a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), and Synklino, a company active in developing a therapeutic protein based therapy as treatment for cytomegalovirus (CMV) infection, announced today that they entered into a Development and Manufacturing Agreement for the recombinant fusion protein SYNx, which Synklino aims to bring into clinical trials.
More info >> |
|
 |
White Papers |
 |
|
Modifying MDI Canister Surfaces to Improve Drug Stability & Drug Delivery
Presspart Manufacturing Ltd
Hydrofluoroalkane (HFA)-based propellants are widely used in modern metered-dose inhalers (MDIs), due to their lack hazardous and environmentally-damaging effects. However, an HFA's active pharmaceutical ingredient can interact with the canister substrate, causing deposition of the drug to the canister walls, or interact with the solution, causing degradation and resulting in increased impurity levels. Over the past few years, a number of surface coatings have been developed that can be applied to MDI canisters and valve components, to protect the contents from deposition and degradation. More recently, plasma processes have been developed to modify and improve the surface energy performance of a MDI canister. This approach has a number of advantages to alternative coatings but requires careful optimisation to ensure the highest quality finish and MDI performance. Richard Turner, Business Development Director, Presspart Manufacturing Ltd, explains.
More info >> |
|
 |
Industry Events |
 |
Formulation and Drug Delivery Series UK
8-9 July 2020, Oxford Global
This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development.
More info >> |
|
|
